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Improved Healing of Pressure 
Ulcers Using Dermapulse, A New 
Electrical Stimulation Device 
Gary D. Gentzkow, MDl 
Sheldon V. Pollack, MD, FRCP, FACPz 
Luther C. Kloth, MS, PT3 
Harrison A. Stubbs, PhD4 
ABSTRACT: A double-blind, clinical study of pulsed electrical stimulation using the 
Dermapulse® device was carried out on 40 pressure ulcers, randomized to receive either active 
(stim) or sham treatment. 
Electrodes were placed over saline-moistened gauze on the ulcers. An electrical current of 35mA 
was delivered to the wound tissues at a frequency of 128 pulses per second. Polarity was negative 
until the wound debrided, then alternated from .positive to negative every three days. Ulcers were 
treated for 30 minutes twice daily for four weeks, after which sham patients could cross over to 
active treatment, and stim patients could continue active treatment. Ulcer healing was determined 
by measuring the length and width of the ulcer and calculating the L x W product. The same clini-
cians measured the ulcers each week, were kept blinded to treatment group, and were not the same 
persons who applied the treatment. 
Nine centers treated 40 ulcers (19 sham and 21 stim). Analysis of the characteristics of the 
patients, the ulcers, and concomitant wound care by both univariate and multivariate analyses 
showed comparability of the groups. After four weeks, the stim ulcers healed more than twice as 
much as the sham ulcers (49.8% vs. 23.4%; (p = 0.042). The stim ulcers healed 12.5% per week com-
pared to 5.8% for the sham group. In the 15 crossover patients, four weeks of active stimulation 
caused nearly four times as much healing as their four weeks of sham treatment (47.9% vs. 13.4%; 
p = 0.012). By the last week of-active stimulation they had healed an average of 64%, and complete 
healing occurred in 40% of these ulcers after an average of nine weeks. Seventeen of the active treat-
ment ulcers had extended therapy, and by their last week of treatment had healed an average of 
75%. Forty-one percent of these ulcers healed completely after an average of 11.8 weeks. There were 
no significant safety problems identified. 
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Pressure ulcers are a major healthcare prob-
lem in the United States. The National Pressure 
Ulcer Advisory Panel, based on the available 
literature, estimated the prevalence of pressure 
ulcers among hospitalized patients to be 
between 3% and 14%, among patients in long 
term care settings between 15% and 25%, and 
between 7% and 12% in home care settings.l 
This translates to more than one million cases, 
and possibly two million cases of pressure 
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ulcers in the U.S.l Various studies estimate the 
cost to heal one ulcer to be from $5,000 to more 
than $25,000, and the total financial burden 
runs well over five billion dollars annually.2 
These wounds often heal slowly, and are asso-
ciated with increased morbidity and mortality.3 
Since the middle of the twentieth century, 
electrical stimulation has been shown to 
improve the healing of wounds in humans4-12 
and experimental wounds in animal models.13-19 
Cell culture studies have shown that electrical 
fields can influence the migratory, proliferative, 
and functional capacity of cells involved in the 
healing process.20-29 Other studies have report-
ed measurements of injury potentials, skin bat-
tery voltages, and wound lateral voltage gradi-
ents which have been theorized to trigger bio-
electric repair and enhancement of wound 
healing.30-38 If electrical signals play a role in 
the stimulation of wound repair, then exoge-
nous application of electric current to chronic 
wounds could be expected to mimic the body's 
bioelectric currents and enhance tissue healing 
processes. Reports from numerous clinical and 
experimental studies provide evidence in sup-
port of this idea.4-29 
Because of different ways of reporting elec-
trical output parameters, the literature at first 
appears chaotic with respect to what kinds of 
stimulation are effective. Reich and Tarjan 
reviewed the literature on the electrical stimu-
lation of wounds in order to determine the 
range of efficacious treatment parameters.39 
When they converted reported outputs to cer-
tain common parameters (current density, total 
charge delivered, and average charge deliv-
ered/ cm2), they found that "successful" treat-
ments were within certain ranges. "Effective" 
treatments delivered a total charge per day 
between 0.1 and 2 coulombs. It was also noted 
that changing polarity during treatment was a 
common procedure. 
The importance of polarity was demonstrat-
ed by Davis, et al in a study of partial thickness 
Wounds in pigs, in which a regimen that uti-
lized negative followed by positive polarity 
Was found to be more effective than other regi-
mens.l6 Other animal studies showed that 
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cathodal (negative polarity) electrical current 
solubilizes dotted blood,30-33 confirming clini-
cal observations that cathodal direct current 
stimulation facilitates debridement of necrotic 
wound tissue, which consists primarily of coa-
lesced blood elements in a protein mesh. 
Current of negative polarity has also been 
shown to be most effective at increasing local 
blood flow.38,39 It has also been demonstrated 
that white blood cells involved in the inflam-
matory phase of wound healing are attracted to 
the negative pole23,25 and that isolated epider-
mal cells, cell clusters and cell sheets migrate 
toward the negative pole.2o Those interested in 
a more complete review of the literature on the 
effects of electrical stimulation on wound heal-
ing are referred to an upcoming article by 
Gentzkow and Miller.42 
Recognizing the need for new, effective 
treatments for pressure ulcers and benefiting 
from previous experimental work, the 
Dermapulse device was developed. It was 
extensively tested in animal models to opti-
mize treatment parameters before a program of 
human testing was undertaken. 
Pressure ulcers are difficult to study for sev-
eral reasons. There is great heterogeneity in the 
size, character, location and chronicity of the 
ulcers, in the basic physical state of the 
patients, and in the "standard" treatments uti-
lized. In order to obtain sufficient numbers of 
ulcers to study, multicenter efforts are neces-
sary. Furthermore, most of the patients are 
elderly and ill, so that controlled trials are fre-
quently interrupted by death, or acute illness 
requiring transfer to another facility. No doubt 
this is why most of the studies published on 
pressure ulcer treatments are anecdotal or lack 
controls, or else report on a small number of 
patients. 
Our randomized, controlled study was 
designed to satisfy current scientific standards, 
to be convincing both to federal regulators and 
to clinicians, and to have enough subjects for 
sound statistical analysis. At the same time, it 
needed to be practical, and easy to carry out in 
multiple investigational sites without unduly 
complicating routines of care. 
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The purpose of this study was to investigate 
the safety and effectiveness of electrical stimu-
lation using the Dermapulse device for the 
treatment of pressure ulcers, as an adjunct to 
standard care. 
Materials and Methods 
Study design. The study was carried out, 
according to a common protocol, at nine inves-
tigational sites with centralized monitoring and 
data analysis. After signing the informed con-
sent, patients who met the selection criteria 
were randomly assigned to receive treatment 
with either an active (stim) or a sham device. 
Devices were identical in appearance and were 
assigned by number. Investigators and patients 
were unaware of whether the device was active 
or sham, and all study procedures were identi-
cal for both groups. 
Patients were treated for 30 minutes twice 
daily for four weeks. Four weeks was chosen as 
the time for efficacy evaluation because investi-
gators were reluctant to keep patients on 
devices that might be sham for longer than 
that. At the end of the four weeks, at the inves-
tigator's discretion, sham patients were 
allowed to cross over to non-blinded active 
treatment, and stim patients could continue to 
be actively treated. 
The primary measure of ulcer healing was 
the relative change in size of the ulcers, deter-
mined by measuring the length and width of 
the ulcer and calculating the L x W product. It 
was recognized that the length x width product 
only estimates the true area of an ulcer. 
Nonetheless, it is quite reproducible and sim-
ple to use clinically, and it is quite useful for 
monitoring changes in ulcer size (change in 
size, not absolute size, was the parameter of 
interest). 
Subject selection. Patients were included if 
they had pressure ulcers that were open and 
Stage II, III or IV. Stages were defined as fol-
lows: Stage II, full thickness skin defect extend-
ing into subcutaneous tissue; Stage III, defect 
extending into muscle; Stage IV, defect extend-
ing to bone or joint structure. (Note: In the no 
widely used IAET staging system, our Stage~ 
would be Stage III, and our Stages III and IV 
would both be Stage IV.) To be included, the 
ulcers were to be between 4 cm2 and 100 cm2in 
area as determined by the L x W product. 
Patients could have more than one ulcer 
entered into the study (the ulcers had to be on 
opposite sides of the body) in which case each 
ulcer was randomized separately, giving the 
possibility that two ulcers would both be sham 
treated, both actively treated, or one of each. 
Patients also had to be cooperative and avail-
able for the duration of the study, and willing 
to sign an informed consent (or have a legal 
representative sign for them). 
Ulcers were excluded from entry into the 
study if they were totally occluded by eschar, 
had bleeding or involving major blood vessels; 
were located in presternal, periorbital, or laryn-
geal/ pharyngeal regions; occurred in subjects 
who were pregnant, wore a cardiac pacemaker, 
had osteomyelitis or peripheral vascular prob-
lems predisposing them to thrombosis; were 
cancerous; or occurred in patients who were on 
long-term steroid therapy, chemotherapy, radi-
ation therapy, or who were very obese. 
Study procedures. Information on each 
patient was obtained concerning age, sex, 
mobility status, systemic medications, systemic 
conditions, and whether they were inpatients 
or outpatients. 
Information on each study ulcer was 
obtained regarding etiology, location, stage, 
duration, past treatment, type of concomitant 
wound treatment used during the study, and 
presence or absence of tunnels or eschar. The 
ulcers were measured for length, width, and 
depth, were charted as to location, and were 
diagrammed on a chart. 
Conventional care was prescribed by the 
physician according to the needs of the individ-
ual patient, and was recorded. In all patients, 
wounds were kept hydrated with saline-
moistened gauze between treatments. 
The treatment regimen was chosen based on: 
unpublished animal studies performed at the 
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University of Miami, Johns Hopkins School of 
Medicine, Duke University Medical Center, 
and the Medical University of South Carolina; 
and previous clinical experiences and pub-
lished animal and clinical studies.4-19 
The study utilized a Derrnapulse stimulator 
as the device to deliver the pulsed electrical 
current. Powered by a six-volt battery, this 
device delivers current at pulse rate/pulse 
duration settings between 2 pps/350 rnicrosec. 
to 128 pps/150 rnicrosec., at intensity settings 
between 0 and 150 rnA., and in either positive 
or negative polarity. It has an automatic timer 
that shuts off the current at the end of the 
30-minute treatment. 
Treatments were given twice per day for 30 
minutes each, with a minimum of four and a 
maximum of eight hours between treatments. 
Identical procedures were followed for sham 
and stirn treated ulcers. 
The ulcer bed was flushed with saline solu-
tion before each treatment and kept moist with 
saline solution between treatments. To enhance 
conduction of electricity to the wound, clean 
4 x 4 gauze pads moistened with saline solu-
tion were placed directly over or into the ulcer. 
The electrode pads were composed of a carbon 
silicone rubber, covered with a cellulose 
sponge with an active contact area of 58 crn2. 
The electrode pad was saturated with saline, 
placed on top of the gauze pads and secured 
into place. For large ulcers, two electrode pads 
were used. 
A large nontreatrnent or return electrode 
was wetted and placed on a large muscle 
group at a minimum distance of 12 inches from 
the ulcer and secured with velcro belts. 
The Derma pulse stimulator controls were set 
to provide pulsed electrical stimulation at a 
rate of 128 pps and an intensity of 35 rnA. 
Using a 58 crn2 electrode, these stimulus 
parameters delivered a charge of 0.89 coulombs 
per 30 minute treatment, or 1.78 coulombs per 
day, which is consistent with the delivered 
energy found to be effective in other studies.39 
The treatment electrode polarity was initial-
ly set as negative and remained that way until 
the ulcer was debrided and a serosanguinous 
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drainage appeared. Thereafter, the polarity was 
switched back and forth from positive to nega-
tive every three days. When the ulcer pro-
gressed to a Stage II classification, the pulse 
rate was changed to 64 pps and the pad polari-
ty was changed each day until the ulcer was 
healed. 
Inpatients were treated by healthcare practi-
tioners. For those at horne, either the patient or 
a family member was trained to apply the stim-
ulator and to document the treatment times 
each day and the machine settings on the daily 
treatment log. 
Only trained healthcare practitioners per-
formed the ulcer measurements, and they were 
kept blinded during the four week study as to 
whether the unit was sham or active. The same 
clinicians measured the ulcers each week, and 
they were not the same persons who applied 
the treatment. 
Safety was assessed daily (by inspection of 
the ulcer and by recording of patient corn-
plaints) and a daily log of treatments was kept. 
At baseline and weekly during treatment, 
the clinicians diagrammed the ulcer and mea-
sured its length, width and depth, and deter-
mined if any tunnels were present. Detailed 
instructions for measuring the ulcers and for 
diagraming the ulcers on the data reporting 
forms were provided in the protocol. The 
length was measured across the longest dis-
tance of the ulcer, the width at the widest dis-
tance across the ulcer. Depth was measured at 
the estimated deepest location of the ulcer, but 
was used only to compare the treatment 
groups at baseline. 
Color photographs were taken biweekly to 
provide a visual record. These were not stan-
dardized nor did they always include a scale in 
the field, and they were not intended for plani-
metric analysis. 
Patients who crossed over or had extended 
therapy continued to have daily safety and 
weekly efficacy assessments as long as they 
were treated. Post-study follow-up was car-
ried out weekly for four weeks for safety and 
to determine if there were any problems and if 
healed ulcers continued to be healed. 
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Table 1. Patient and ulcer characteristics by treatment For continuous variables such as age, dura~ 
group. tion of ulcer, and percent healed, statistical 
comparisons of the stim and sham groups were 
SHAM STIM TOTAL performed using the two sample Student's 
Age t-test. This test was used with the pooled vari-
Mean 62.2 63.3 62.8 ance estim~te if there was no evidence of differ-
SD 18.4 17.8 17.6 ences in the variances at the 5% level by 
Range 31-90 29-91 29-91 Cochran's test. Where there was evidence of 
Sex significantly different variances, the test was 
Male% 47.4 61.9 55.0 employed using the separate variance esti-
Female% 52.6 38.1 45.0 mates for the two groups with the degrees of 
Initial Ulcer Area (cm2) freedom adjusted accordingly. 
Mean 12.5 19.2 16.0 For categorical variables, e.g. sex, or tun-
(SD) (11.9) (23.2) (18.79) nels I undermining, the stim and sham groups 
Initial Ulcer Depth (em) were compared using the chi square test. Yate' s 
Mean 1.4 1.1 1.2 correction for continuity was used for dichoto-(SD) (2.3) (2.1) (2.2) mous variables. 
Stage Stepwise multiple discriminant analysis was 
II 1 0 1 employed to ascertain factors or combinations III 14 16 30 
IV ~ 2 _2_ of baseline characteristics that might distin-
Total 19 21 40 guish the stim and sham groups. 
Location Stepwise multiple regression analysis was 
Hip /Ischium 6 9 15 performed to explore and model the possible 
Sacrum/ Coccyx 8 4 12 effects of various factors and treatment group 
Leg 1 2 3 on treatment outcome as indicated by percent 
Foot ~ _Q 10 healed. 
Total 19 21 40 Three-way analysis of variance was per-
Duration % % % formed to evaluate the separate effects on per-
<1 month 11.1 20.0 15.8 cent healed of investigational center or ulcer 
1 to 3 16.7 5.0 10.5 location when considered with treatment 
3 to 6 22.2 25.0 23.7 group and tunnels/undermining. 
6 to 12 16.7 35.0 26.3 For crossover ulcers, the paired t-test was 
>12 33.3 15.0 23.7 used to compare the percent healed during the 
Tunnels/Undermining % % % four-week sham and active stimulation 
Yes 26.3 38.1 32.5 periods. 
No 73.7 61.9 67.5 For this report, all references to statistical 
Eschar % % % 
significance are based on the 0.05 significance 
Yes 21.1 28.6 25.0 level for two-tailed tests, unless otherwise 
No 78.9 71.4 75.0 specified. 
Results 
Enrollment and exclusion from analysis. 
Statistical methods. It was calculated that Forty-nine ulcers (24 sham, 25 stim) were 
approximately 23 patients per group would be enrolled into the study at nine investigational 
needed to detect differences of 15% or more in sites. Six ulcers (4 sham, 2 stim) were excluded 
percent healed at four weeks, with an alpha from analysis because they received less than 
error of 0.05 and a power of 80%, and an esti- four weeks of treatment and thus did not have 
mated variance of 18%. enough data for analysis. Three ulcers (1 sham, 
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Table 2. Part 1 
Summary of results of the statistical tests used to compare the SHAM and STIM groups of comparability of patients and ulcer 
characteristics. 
1 All chi-square values for fourfold tables include Yate's correction for continuity. 
2 With adjustment for heterogeneity of variances. 
Characteristics Statistical Test Test Statistic 
Sex chi-square1 0.37 
Age t-test 
-0.18 
Wound stage chi-square 1.15 
Duration t-testz 1.34 
chi-square 4.28 
Tunnels/Undermining chi-square 0.21 
Initial Wound: 
size (L x W) t-testz 
-1.18 
depth t-test 0.44 
Previous Treatment: 
conservative chi-square 0.81 
debridement chi-square 0.45 
antibiotics chi-square 0.02 
medication chi-square 0.09 
Sytemic conditions: 
cardiovascular chi-square 0.17 
central nervous chi-square 0.00 
metabolic chi-square 0.04 
musculoskeletal chi-square 0.82 
Degree of mobility chi-square 0.29 
In/ out patient chi-square 0.00 
Eschar chi-square 0.03 
Receiving Treatment 
for other conditions: 
antibiotics chi-square 0.03 
diabetics chi-square 0.02 
cardiovacular chi-square 0.00 
psychotropic chi-square 0.32 
Concomitant Therapy: 
surgical or 
whirlpool therapy 
bedrest & elevation 
chi-square 0.00 
of extremity chi-square 0.00 
Part 2. 
Degree of Significance Value 
Freedom (p-value) 
1 0.55 
38 0.86 
2 0.56 
20.94 0.20 
4 0.37 
1 0.65 
30.46 0.25 
38 0.66 
1 0.37 
1 0.50 
1 0.88 
1 0.76 
1 0.68 
1 1.00 
1 0.85 
1 0.37 
2 0.86 
1 1.00 
1 0.86 
1 0.86 
1 0.88 
1 1.00 
1 0.57 
1 1.00 
1 1.00 
A stepwise discriminate analysis of factors potentially differentiating the treatment groups was done 
Using the characteristics listed in Part 1. None of these characteristics alone or in combination was found 
to be statistically different between treatment groups at the 0.10 significance level. 
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2 stim) were excluded from analysis because of 
serious protocol violations which made it 
impossible to analyze critical data. Patients 
were not excluded for minor protocol viola-
tions, and every effort was made to include as 
many patients in the analysis as possible. 
Overall, 40 I 49 ulcers (19 sham, 21 stim) or 
81.6% were included in the analysis. These 40 
ulcers were on 37 patients; three patients each 
had two ulcers included in the analysis. The 
randomization resulted in approximately equal 
numbers of pressure ulcers being enrolled in 
the sham and stim groups overall and at each 
center. Nearly equal numbers in each group are 
included in the analysis as well. 
Patient, ulcer, and care characteristics. Table 
1 lists the key characteristics of the patients and 
the ulcers for the sham and stim groups. 
Patient ages ranged from 29 to 91 years. The 
mean ages of the patients in the sham and stim 
groups were nearly identical, 62.2 and 63.3 
years respectively. Overall, there were 55% 
males and 45% females, but there was a higher 
proportion of females in the sham group than 
the stim group (52.6% vs. 38.1 %). 
The mean initial ulcer area was somewhat 
larger in the stim group (19.2 vs. 12.5 cm2), 
while the sham group had slightly deeper 
ulcers (1.4 vs. 1.1 em). Nine of the wounds 
were Stage IV, 30 were Stage III, and the only 
Stage II wound was in the sham group. 
Location of ulcers were: hip/ischium 15, 
sacrum I coccyx 12, leg 3, and foot 10. The 
ulcers were distributed similarly between the 
groups. Duration of the ulcers prior to the 
study was also similar in both groups, with 
15.8% less than one month, 10.5% 1 to 3 
months, 23.7% 3 to 6 months, 26.3% 6 to 12 
months, and 23.7 greater than a year. 
Tunnels I undermining of the ulcer were pre-
sent somewhat more often in the stim group, 
38.1% vs. 26.3%. About one-fourth of the ulcers 
in each group had eschar on them at the begin-
ning of the study. 
Not shown in Table 1 are additional baseline 
data. Approximately 80% of each group were 
treated as inpatients. Nearly equal percentages 
of each group were bedbound (50%) 
wheelchair bound (42%) or ambulatory (8%)~ 
There were no meaningful differences in the 
type of care the ulcers had received prior to the 
study, the systemic conditions of the patients, 
or the drugs they were taking. 
The type of concomitant ulcer care (in addi-
tion to the electrical stimulation procedures) 
provided during the study was recorded, and 
virtually identical percentages of sham and 
stim ulcers received normal saline and dress-
ings (100%), surgical or whirlpool debridement 
(10%) turning to relieve pressure (100%), or bed 
rest and elevation of an extremity (55%). 
Comparability of sham and stim groups. It 
is of critical importance to determine if the 
active treatment (stim) and control (sham) 
groups were comparable at the time of enroll-
ment, as a check that randomization produced 
comparable groups and to see if any factors 
that are correlated with the healing of the 
ulcers existed. Univariate and multivariate 
comparisons of the groups for characteristics 
for which data were gathered were performed 
and are listed in Table 2. None of the variables 
was significantly different between the groups, 
nor did any variable even approach statistical 
significance at the 0.05 or 0.10 significance 
level. 
It can be concluded that there was no statis-
tical evidence of differences between the two 
treatment groups at baseline and the significant 
differences in treatment outcome are not likely 
to be attributable to any differences in group 
characteristics. 
Efficacy: Four week double-blind results. 
As shown in Table 3, at four weeks the stim 
group had healed more than twice as much as 
the sham group (49.8% vs. 23.4%), a rate of 
12.5% per week versus 5.8% per week. This dif-
ference was statistically significant (p = 0.042). 
Inspection of the standard deviations also 
shows that the variability in healing response 
was less with active treatment. Figure 1 graphi-
cally displays the rate of healing for the two 
groups over the four weeks of the blinded 
study. 
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Table 3 
Treatment Weekl Week2 Week3 Week4 
Group % % % % 
SHAM 3.7 10.2 23.1 23.4 
(N=19) 
(SO) (25.7) (38.1) (40.3) (47.4) 
STIM 18.0 33.2 35.1 49.8 
(N= 21) 
(SO) (19.6) (29.0) (36.1) (30.9) 
PValue 0.053 0.037 0.325 0.042 
SO = Standard Deviation 
P values are calculated by T-Test, 38 degrees of 
freedom, two-tailed 
Table 3. Percentage of ulcer healed at weeks 1,2,3, and 4 
for the SHAM and STIM groups. Each patient's wound 
area at each week was compared to the area at baseline, and 
the percentage healed was calculated. The data reported are 
the mean of these individual percentages. 
The foregoing univariate analysis does not 
adjust for any factors other than treatment 
group which might be associated with treat-
ment outcome. Consequently, a stepwise multi-
ple regression analysis was performed to assess 
the possible simultaneous effects of various 
potential co-factors on the four week mean 
percentage of ulcer healed. The same character-
istics of the patients, their ulcers, and concomi-
tant wound therapy listed on Table 2 were 
employed in this analysis as potential predic-
tors of treatment outcome. 
Table 4 lists the five variables that were 
found to meet the 0.05 significance criterion. 
The multiple regression coefficient for these 
data (R = 0.751) is quite high. Not surprisingly, 
treatment group was significantly associated 
With outcome. Metabolic condition, having 
tunnels I undermining in the ulcer, sex, and 
stage of the ulcer are also associated with out-
come. The fitted model derived from this anal-
ysis can be expressed as follows: The expected 
percentage healed after four weeks: +41.41% if 
Vol. 3, No.5, September/October 1991 
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0~~~~----~-------------
INITIAL WEEK 1 WEEK 2 WEEK 3 WEEK4 
00 SHAM ill STIM 
Figure 1. The percentage of the ulcer healed (Mean +1-
SEM) at weeks 1,2,3, and 4 for the SHAM control group 
(lower line) versus the percentage healed for the actively 
treated STIM group (upper line). Each patient's wound 
area at each week was compared to the area at baseline, and 
the percentage healed was calculated. The data reported are 
the mean of these individual percentages. 
actively stimulated, +27.17% if the patient has a 
metabolic condition, +26.32% if the patient is 
female, -37.40% if tunnels/undermining are 
present, -22.28% if Stage IV vs. III (or III vs. II). 
Although none of these variables was signif-
icantly different between the treatment groups, 
if there were any bias in the results due to 
imbalances in the treatment groups, this would 
be expected to work against finding an effect of 
the active treatment because the stim group 
had fewer patients with metabolic conditions 
(mainly diabetes), fewer females, more tunnels, 
and slightly higher stages than the sham group. 
Since treatment by electrical stimulation 
(treatment group) and presence of tunnels/ 
undermining were already determined by the 
stepwise multiple regression analysis to have 
major effects on healing rates, it was possible to 
look at the individual effects of other categori-
cal factors when combined with those two fac-
tors in a three-way ANOVA. Whereas treat-
ment group and tunnels/undermining were 
still found to be significantly associated with 
outcome (p < 0.05), this analysis provided no 
evidence of an effect on outcome due to either 
anatomic location (p = 0.71) or investigational 
center (p = 0.28). 
Patients who crossed over from sham to 
active stimulation. At the end of the four week 
study period the investigators could cross over 
165 
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Table 4. 
Stepwise multiple regression analysis of mean percentage of wound healed as a possible function of vari-
ous factors including treatment group. 
Step Variable Multiple R R2 Partial R2 Coefficient* p-value* 
1 Metabolic Condition 0.391 0.153 0.153 27.17 0.0227 
2 Treatment group 0.539 0.291 0.138 41.41 0.0003 
3 Tunnels 0.632 0.400 0.109 -37.40 0.0027 
4 Sex 0.709 0.502 0.102 26.32 0.0141 
5 Stage 0.751 0.563 0.061 -22.28 0.0419 
(constant) 52.72 0.1763 
No other variables met the 0.05 significance level. 
* as of final equation 
Table 4. Results of the multiple regression analysis undertaken to determine factors associated with wound healing. 
the sham ulcers to unblinded active therapy. Of 
the 19 sham ulcers with analyzable four-week 
data, 15 were crossed over, completed at least 
four weeks of active therapy, and continued for 
a mean total of 9.8 weeks (range 5 to 16 weeks) 
of active stimulation. At the end of the sham 
treatment period these ulcers had healed only 
an average of 13.4 percent. After four weeks of 
active stimulation they had healed an average 
of 47.9 percent of their size at the time of 
crossover. This fourfold greater healing during 
four weeks of stim versus four weeks of sham 
in the same ulcers is statistically significant 
(p = 0.012; t-test, two-tailed). 
The average healing after four weeks of 
active stimulation in these ulcers (47.9%) was 
almost identical to the healing after the first 
four weeks (49.8%) in the active treatment 
group, indicating a consistent treatment effect. 
By their last week of active treatment the 
crossover ulcers had healed an average of 63.9 
percent. Forty percent of the ulcers healed com-
pletely, after an average of nine weeks. 
Extended therapy in active treatment 
patients. Of the 21 patients in the active treat-
ment group, 17 received additional stimulation 
beyond the first four weeks of therapy. The 
total duration of stimulation (including the first 
four weeks) averaged 10.7 weeks, with a range 
of 5 to 26 weeks. After their initial four weeks 
of therapy, these patients had healed an aver-
age of 45.0%; by their last week of therapy they 
had healed an average of 74.6%. Forty-one per-
cent of the ulcers healed completely, after an 
average of 11.8 weeks therapy. 
Post-study follow-up. Four-week post-
study follow-up did not reveal any adverse 
effects of treatment in any of the ulcers. All of 
the ulcers that were completely healed during 
the initial study, after crossover, or during 
extended therapy were still healed at 
follow-up. Three ulcers had not quite healed 
during active treatment but were fully healed 
upon follow-up. 
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Safety. There were no significant safety 
problems during the study and no patient was 
withdrawn because of an adverse event. The 
only complaints that could be attributed to the 
active treatment were uncomfortable sensa-
tions in the ulcer when the current was turned 
on, which occurred in 13.6% of ulcers during 
active treatment versus 4.2% of ulcers during 
sham treatment. 
Discussion 
This double-blind, randomized, placebo-
controlled, multicenter study demonstrated the 
safety and effectiveness of pulsed electrical 
stimulation, utilizing the Dermapulse device, 
for the promotion of healing of pressure ulcers. 
During the four weeks of double-blinded treat-
ment, the stimulated ulcers healed more than 
twice as much as the sham ulcers and this dif-
ference was statistically significant. Multiple 
regression analysis confirmed a highly signifi-
cant positive association of active stimulation 
with amount of ulcer healing. These healing 
rates are consistent with those reported in 
other studies of electrical stimulation.4-10 In 
comparing these rates of healing, it should also 
be noted that these were all severe pressure 
ulcers, with all but one meeting the IAET crite-
ria of Stage IV. 
Some degree of healing in the sham group 
was not surprising because of the increased 
care given to the ulcers as part of the study 
procedures, and the maintenance of a moist 
wound environment. But active treatment sig-
nificantly added to this "non-specific" treat-
ment effect. The sham group did not show any 
further healing between weeks three and four, 
suggesting that the "non-specific" healing 
effects may have reached their maximum at 
three weeks. 
Controlled clinical studies of pressure ulcers 
are inherently difficult. Nonetheless, this study 
fulfills the generally accepted criteria for a 
well-controlled trial. It was carried out in com-
pliance with the Institutional Review Board 
and Informed Consent regulations. Blinding 
and randomization were done carefully and 
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systematically. Investigators were trained in 
study procedures and agreed to conduct the 
study in compliance with FDA regulations. The 
study sites were closely monitored to insure 
compliance with protocol procedures and 
record-keeping requirements. Problems that 
arose in study conduct were identified and cor-
rected. Analysis of data was carried out using 
accepted statistical techniques and included 
multiple analyses to characterize baseline and 
outcome parameters. 
Multivariate analysis also indicated that 
metabolic condition and female sex were asso-
ciated with better healing, and that presence of 
tunnels I undermining and a more severe stage 
of ulcer were associated with poorer healing. 
To the extent that the treatment groups were 
unbalanced with regard to these characteristics, 
the difference favored the sham group in every 
case. Based on these results, if there was any 
bias in the results due to these factors it would 
have been expected to work against finding an 
effect of the active treatment. 
One potential weakness in the study design 
is the use of the length x width product to esti-
mate wound size. In designing this study, other 
techniques such as photography with planime-
try and tracings were considered. In order to be 
reproducible and accurate, photography 
requires expensive and extensive controls. Each 
center must be provided with standardized 
cameras and flash units and a means of con-
trolling exposure, lighting, and focal distance. 
The angle of the photograph is critical and 
variations in angle may give false data on 
planimetric analysis. Wounds that curve 
around a body part are especially difficult to 
photograph accurately. Small changes in the 
position of the patient when photographing 
mobile tissue, such as the gluteal areas, can 
greatly distort the wound outline. Tracing is 
subject to many of these same problems, and 
still requires expensive planimetric analysis. 
For these reasons, we did not choose to use 
these techniques in this study. 
It was recognized that the length x width 
product only estimates the true area of a 
wound. Nonetheless, it is quite reproducible 
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and simple to use clinically, and it is quite use-
ful for monitoring changes in wound size 
(change in size, not absolute size, was the 
parameter of interest). If one were trying to dis-
tinguish quite small changes between treat-
ments it would be more problematical, but the 
magnitude of changes observed in this study 
are quite readily measurable by this technique. 
Furthermore, the photographic record, though 
not adequate for planimetric analysis, at least 
provided visual confirmation of the large 
changes in wound size. 
The results also point out that four weeks 
was a long enough study period to demon-
strate significantly different healing results 
between the sham and stim groups, but was 
not long enough in most patients to produce 
complete healing. Complete healing required 
nine to twelve weeks treatment on the average. 
Not all ulcers were continued long enough 
to determine if complete healing would occur. 
The usual reason for incomplete healing in the 
study was that therapy was stopped before 
complete healing took place. Of necessity, the 
experimental therapy, following a detailed pro-
tocol, and demanding extensive documenta-
tion, can only be carried out at specially desig-
nated investigational sites. Thus, for example, 
when a nursing home patient experiences an 
intercurrent illness and must go to the acute 
care hospital for a few days, the study is termi-
nated for that patient. 
The treatment proved to be extremely safe. 
There were no significant safety problems iden-
tified and no patient was withdrawn from the 
study because of an adverse event or skin irri-
tation. The only treatment-related adverse 
events were the occurrence of uncomfortable 
sensations in the ulcers at the time of treat-
ment, which happened in 13.6% of the stim 
ulcers versus 4.2% of the sham ulcers. All of 
these happened only once or twice during 
weeks of treatment and only at the beginning 
of therapy. Since sensations were perceived by 
only a minority of patients, some in each 
group, and only once or twice during all of the 
treatments, we do not believe this compro-
mised the blinding. 
We conclude that in this study pulsed elec-
trical stimulation using the Dermapulse device 
was safe and effective for the promotion of 
healing of pressure ulcers as an adjunct to stan-
dard ulcer care, and suggest that it may prove 
to be an important addition to the care of this 
important health problem. 
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